AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2024
May 1, 2024
30786_dirs_2024-05-01_04464c5b-69e7-4ee0-9145-0c53d97fedf7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2023-05-03
Reporting Person: SCHWARTZ STEVEN D (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-03 | Bio-Rad A Common Stock | S | 320 | $463.86 | Disposed | 1498.0335 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad B Common Stock | 25177 | Direct |
| Bio-Rad A Common Stock | 362146 | Direct |
| Bio-Rad B Common Stock | 12949 | Indirect |
| Bio-Rad B Common Stock | 4060054 | Indirect |
Footnotes
F1: Total reflects the number of shares beneficially owned by the insider as of the date of the report.
F2: The reporting person disclaims beneficial ownership of these shares.
F3: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13